EDAP TMS SA (EDAP)
3.53
+0.16
(+4.75%)
USD |
NASDAQ |
Apr 15, 16:00
3.53
0.00 (0.00%)
After-Hours: 20:00
EDAP TMS Research and Development Expense (Annual) : 10.13M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| DBV Technologies SA | 107.12M |
| Cellectis SA | 75.08M |
| Akari Therapeutics Plc | 2.822M |
| Biodexa Pharmaceuticals Plc | 5.026M |
| Mereo BioPharma Group Plc | 17.81M |